Vascular-stromal function and regulation in immunity
血管基质功能和免疫调节
基本信息
- 批准号:10062843
- 负责人:
- 金额:$ 44万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-02-01 至 2022-11-30
- 项目状态:已结题
- 来源:
- 关键词:AffectAntibodiesAreaAutoimmune DiseasesB-LymphocytesBloodBlood VesselsCCL2 geneCell SurvivalCell physiologyCellsChimera organismChronicDataDendritic CellsDependenceDiseaseElementsEndothelial CellsFibroblastsGoalsHealthHomeostasisImmuneImmune System DiseasesImmune responseImmune systemImmunityImmunizationLigandsLinkLupusLymphaticLymphocyteLymphoid TissueLymphoproliferative DisordersMediatingMesenchymalModelingMyeloid CellsPathologicPermeabilityPhasePhenotypePlasma CellsPlasmablastPlayProcessRegulationReticular CellRoleRunningSeriesSinusSiteTestingTissuesUp-RegulationVascular DiseasesVascular PermeabilitiesVascular Permeability Alterationarginasecardiovascular healthinsightlymph nodespodoplanin
项目摘要
Summary
Lymphocytes within lymphoid tissues are regulated by a vascular-stromal compartment comprised of blood
vessels, lymphatic sinuses, and non-vascular mesenchymal reticular cells, and understanding the functions
and regulation of this compartment can have implications for better understanding and treating
lymphoproliferative and autoimmune diseases. We have recently shown that fibroblastic reticular cells (FRCs)
are in distinct functional states at homeostasis and in inflamed lymph nodes. Our long-term goal is to
understand other functional features of the vascular-stromal compartment in inflamed nodes, how these
features contribute to regulating immune responses, and how these features in inflamed nodes are induced.
Here, we show that FRCs upregulate CCL2 during a phase of the immune response that corresponds to
plasma cell accumulation. FRCs express CCL2 at high levels in the vascular-rich medulla and vascular-rich
regions of the T zone, which are also the sites of plasma cell localization. We show that CCL2 limits plasma
cell survival and that vascular permeability may play a role in inducing the FRC functional phenotype in these
vascular-rich regions. We propose to test the hypothesis that, during this phase of the immune response,
features of vascular-rich microenvironments regulate plasma cell function and vascular activity regulates FRC
functional phenotype in these areas. Our aims are 1) to understand how CCL2 regulates plasma cell survival
and 2) to understand how vascular activity contributes to modulating FRC functional phenotype. The results
from this proposal will provide new insights into lymphoid tissue vascular-stromal function and regulation,
plasma cell regulation, and a potential link between cardiovascular health and the immune system. This link is
especially relevant for autoimmune diseases such as lupus that are characterized both by vascular dysfunction
and immune system dysfunction marked in part by plasma cell accumulation
总结
淋巴组织内的淋巴细胞受血管间质区室的调节,
血管,淋巴窦和非血管间充质网状细胞,并了解其功能
调节这个区室可以更好地理解和治疗
淋巴增生性和自身免疫性疾病。我们最近发现成纤维网状细胞(FRC)
在体内平衡和发炎的淋巴结中处于不同的功能状态。我们的长期目标是
了解炎症结节中血管间质室的其他功能特征,这些功能如何影响淋巴结的功能。
特征有助于调节免疫反应,以及炎症节点中的这些特征是如何诱导的。
在这里,我们表明,FRC上调CCL2在一个阶段的免疫反应,对应于
浆细胞积聚。FRC在富含血管的髓质中高水平表达CCL 2,
T区的区域,这也是浆细胞定位的位点。我们表明,四氯化碳限制血浆
细胞存活和血管通透性可能在诱导FRC功能表型中起作用,
血管丰富的区域。我们建议测试的假设,在这一阶段的免疫反应,
富含血管的微环境调节浆细胞功能,血管活性调节FRC
功能表型在这些领域。我们的目标是1)了解CCL2如何调节浆细胞存活
和2)了解血管活性如何有助于调节FRC功能表型。结果
从这个建议将提供新的见解淋巴组织血管基质的功能和调节,
浆细胞调节,以及心血管健康和免疫系统之间的潜在联系。这个环节
尤其与自身免疫性疾病相关,例如狼疮,其特征在于血管功能障碍
以及免疫系统功能障碍,部分表现为浆细胞积聚
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Theresa T. Lu其他文献
Theresa T. Lu的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Theresa T. Lu', 18)}}的其他基金
Diversity supplement: Lymphatic regulation of lymph node function in lupus
多样性补充:狼疮淋巴结功能的淋巴调节
- 批准号:
10794867 - 财政年份:2023
- 资助金额:
$ 44万 - 项目类别:
Vascular-stromal function and regulation in immunity
血管基质功能和免疫调节
- 批准号:
10312108 - 财政年份:2010
- 资助金额:
$ 44万 - 项目类别:
Lymphatic regulation of lymph node function in lupus
狼疮淋巴结功能的淋巴调节
- 批准号:
10587191 - 财政年份:2010
- 资助金额:
$ 44万 - 项目类别:
相似海外基金
University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
- 批准号:
10073243 - 财政年份:2024
- 资助金额:
$ 44万 - 项目类别:
Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
- 批准号:
10752129 - 财政年份:2024
- 资助金额:
$ 44万 - 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
- 批准号:
2339201 - 财政年份:2024
- 资助金额:
$ 44万 - 项目类别:
Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
- 批准号:
MR/Y008693/1 - 财政年份:2024
- 资助金额:
$ 44万 - 项目类别:
Research Grant
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
- 批准号:
23K14783 - 财政年份:2023
- 资助金额:
$ 44万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
- 批准号:
23KJ0394 - 财政年份:2023
- 资助金额:
$ 44万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
- 批准号:
10076445 - 财政年份:2023
- 资助金额:
$ 44万 - 项目类别:
Grant for R&D
PLA2G2D Antibodies for Cancer Immunotherapy
用于癌症免疫治疗的 PLA2G2D 抗体
- 批准号:
10699504 - 财政年份:2023
- 资助金额:
$ 44万 - 项目类别:
Genetic adjuvants to elicit neutralizing antibodies against HIV
基因佐剂可引发抗艾滋病毒中和抗体
- 批准号:
10491642 - 财政年份:2023
- 资助金额:
$ 44万 - 项目类别:
Novel Immunogens to Elicit Broadly Cross-reactive Antibodies That Target the Hemagglutinin Head Trimer Interface
新型免疫原可引发针对血凝素头三聚体界面的广泛交叉反应抗体
- 批准号:
10782567 - 财政年份:2023
- 资助金额:
$ 44万 - 项目类别:














{{item.name}}会员




